The Great Reshuffling: Stocks That Will Win the Next Decade

The Great Reshuffling: Stocks That Will Win the Next Decade

a man wearing glasses and a black shirt

Parth Patel

Oct 2, 2025

15 min

The Great Reshuffling: Which Stocks Will Dominate the Next Decade?

JPMorgan's "Navigating the Future" report reveals three seismic shifts poised to separate winners from losers by 2035

The pace of technological change has never been faster—and it will never be this slow again. JPMorgan's Corporate Finance Advisory team just released their strategic outlook for the next decade, and the implications for investors are staggering. Three converging forces—artificial intelligence breakthroughs, energy market transformation, and healthcare longevity advances—will create the widest performance gap between winning and losing stocks in modern market history.

Here's what the data reveals about which companies will thrive and which face obsolescence.

The AI Revolution: Knowledge Workers First, Manufacturing Maybe Never

ChatGPT reached 100 million users in 2 months. Netflix took 10 years. That adoption velocity tells you everything about AI's disruptive potential.

JPMorgan's six-factor AI leverage model assessed every S&P 500 sector on efficiency opportunity, innovation potential, and adaptability. The verdict: services sectors dominate, manufacturing lags—a complete reversal from previous technological revolutions.

AI Winners: The Knowledge Economy Elite

Pharmaceuticals & Biotechnology

  • Stocks to watch: Eli Lilly LLY, Novo Nordisk NVO, Vertex Pharmaceuticals VRTX, Moderna MRNA

  • Catalyst: AI slashes drug development timelines by 30-50%, with trials using machine learning showing 25-30% faster completion rates

  • Risk: $880 million average drug development cost remains barrier despite AI efficiencies

Software & Services

  • Stocks to watch: Microsoft MSFT, Alphabet GOOGL, Salesforce CRM, ServiceNow NOW, Palantir PLTR

  • Catalyst: Low revenue-per-employee models gain massive leverage; coding assistants increase developer productivity 25-30%

  • Risk: Talent wars intensify; smaller players face commoditization

Financial Services

  • Stocks to watch: JPMorgan Chase JPM, Visa V, Mastercard MA, S&P Global SPGI, BlackRock BLK

  • Catalyst: Process automation drives margin expansion; fraud detection accuracy improvements exceed 90%

  • Risk: Regulatory complexity; cybersecurity vulnerabilities scale with AI adoption

Semiconductors

  • Stocks to watch: NVIDIA NVDA, Taiwan Semiconductor TSM, ASML ASML, Broadcom AVGO, AMD AMD

  • Catalyst: Hyperscaler capex growing 32% CAGR since 2020; data center demand structural not cyclical

  • Risk: $420 billion in committed AI capex through 2026 creates oversupply risk if adoption slows

AI Losers: Physical World Constraints

Consumer Staples & Food

  • Vulnerable names: Kraft Heinz KHC, Campbell Soup CPB, Conagra CAG

  • Problem: Low gross margins per employee; limited R&D leverage; physical distribution bottlenecks

  • Reality check: AI can't fundamentally change the economics of moving tomato soup from factory to shelf

Automobiles

  • Mixed outlook: Traditional OEMs lag (Ford F, GM GM) while EV-native companies (Tesla TSLA) maintain advantage

  • Problem: Capital-intensive manufacturing; autonomous vehicle timeline remains 5-10 years out despite hype

  • Exception: Auto suppliers with software focus (Aptiv APTV) positioned better than vehicle assemblers

The Energy Paradox: Short-Term Pain, Long-Term Abundance

AI's voracious power appetite creates a fascinating market dynamic: near-term price spikes followed by structural deflation as investment floods into generation capacity.

The Near-Term Crunch (2025-2027)

PJM capacity auction prices jumped from $2.2 billion to $16.1 billion—a 632% increase—as data center demand outpaced grid expansion. Hyperscaler capex projections keep getting revised upward: Microsoft alone announced then delayed $80 billion in data center buildouts.

Vulnerable to Energy Spikes:

  • Transportation: United Airlines UAL, FedEx FDX, Norfolk Southern NSC—fuel represents 50% of operating costs

  • Materials: Alcoa AA, Nucor NUE, Mosaic MOS—energy-intensive production loses competitiveness

  • Industrial Manufacturing: Caterpillar CAT, Deere DE face margin compression

The Long-Term Flip (2030-2050)

North American utility capex rising 18% annually through 2029, with 94 GW of new capacity planned (60% nuclear, 28% gas). Renewable electricity costs fell 88% for solar since 2009, with fusion commercialization targeting early 2030s.

Energy Deflation Beneficiaries:

Stock

Ticker

Catalyst

Timeframe

Transportation

Union Pacific (UNP), CSX (CSX)

Fuel costs decline 60-80%; margins expand 500-1000 bps

2030+

Data Centers

Equinix (EQIX), Digital Realty (DLR)

Power constraints removed; capacity doubles

2028-2035

Semiconductors

Intel (INTC), Micron (MU)

Fab operating costs fall 40-60%

2030+

Materials

Freeport-McMoran (FCX), Steel Dynamics (STLD)

Energy-intensive production becomes advantage

2032+

Energy Transition Winners:

  • Utilities executing capex: NextEra Energy NEE, Duke Energy DUK, Southern Company SO

  • Grid infrastructure: Quanta Services PWR, MasTec MTZ

  • Renewable developers: First Solar FSLR, Enphase ENPH

  • Nuclear: Constellation Energy CEG, Vistra VST

  • Battery storage: Tesla Energy, Fluence (private)

Energy Transition Losers:

  • Fossil fuel producers: ExxonMobil XOM, Chevron CVX face structural demand decline

  • Coal exposure: Peabody Energy BTU, Arch Resources ARCH

  • Stranded asset risk: Pipeline operators with 30-year contracted cash flows (Kinder Morgan KMI, Williams Companies WMB)

The Longevity Boom: Healthcare Transforms Retirement Economics

GLP-1 drugs (Ozempic, Wegovy, Mounjaro, Zepbound) reached 3rd-most prescribed medication status in history. Pipeline approvals through 2028 expand indications to heart failure, Alzheimer's, chronic kidney disease, and 5+ additional conditions.

Life expectancy gains of 2 years create $2.4-$16.4 trillion in economic value through changed consumption patterns—but also generate $3.2 trillion in Medicare/Social Security costs and $148 billion in unfunded corporate pension liabilities for S&P 500 companies.

Healthcare Longevity Winners

Pharmaceuticals (GLP-1 Leaders)

Company

Ticker

Drug Franchise

2024-2028 Opportunity

Eli Lilly

LLY

Mounjaro/Zepbound (tirzepatide)

Cardiovascular, MASH, CKD approvals expand TAM 300%

Novo Nordisk

NVO

Ozempic/Wegovy (semaglutide)

Alzheimer's, diabetic retinopathy trials de-risk pipeline

Amgen

AMGN

MariTide (maridebart café)

2028 launch targets GLP-1 adherence problem

Healthcare Equipment & Diagnostics

  • AI-powered diagnostics: Intuitive Surgical ISRG, Dexcom DXCM, Abbott Labs ABT

  • Aging population tailwinds: Medtronic MDT, Stryker SYK, Boston Scientific BSX

  • Remote monitoring: Teladoc TDOC—turnaround candidate if execution improves

Gene Therapy & Longevity

  • CRISPR leaders: CRISPR Therapeutics CRSP, Editas Medicine EDIT, Intellia Therapeutics NTLA

  • Longevity biotech: Unity Biotechnology UBX, Geron GERN—high risk/reward

Senior Housing & Services

  • REITs: Welltower WELL, Ventas VTR, Healthpeak Properties PEAK

  • Services: Brookdale Senior Living BKD—turnaround story if occupancy improves

Longevity-Driven Headwinds

Pension Liability Explosion

  • Heavy exposure: General Electric GE, Lockheed Martin LMT, Raytheon RTX, Boeing BA

  • Problem: 3-year life expectancy increase = 10% jump in pension obligations

  • De-risking leaders: Prudential PRU, Athene (merged with Apollo APO) facilitate pension risk transfers

Consumer Staples Disruption

  • Processed food vulnerable: Mondelez MDLZ, General Mills GIS, Kellogg's K

  • Reality check: Healthier aging populations consume less packaged/processed foods; GLP-1 users reduce calorie intake 20-30%

Life Insurance Repricing

  • Actuarial model disruption: MetLife MET, Prudential PRU, Lincoln National LNC

  • Required action: Premium restructuring as mortality assumptions shift 15-20%

Cross-Scenario Synthesis: The Multi-Threat Winners

The truly exceptional opportunities sit at the intersection of all three scenarios:

Triple-Leverage Stocks

1. Eli Lilly (LLY)

  • AI advantage: Drug discovery AI reduces R&D costs 30-40%

  • Energy benefit: Minimal energy intensity; knowledge-based business model

  • Healthcare catalyst: GLP-1 franchise expanding into 8+ conditions; $50+ billion revenue potential by 2030

2. NVIDIA (NVDA)

  • AI advantage: 80%+ market share in AI accelerators; software moat strengthens

  • Energy benefit: Data center expansion benefits from cheap power post-2030

  • Healthcare crossover: Medical imaging AI, drug discovery partnerships

3. Microsoft (MSFT)

  • AI advantage: Azure AI services; Copilot productivity gains; OpenAI partnership

  • Energy benefit: Demand response programs manage data center costs; long-term power deflation

  • Healthcare exposure: Nuance Communications acquisition positions for medical AI

4. UnitedHealth Group (UNH)

  • AI advantage: Claims processing automation; fraud detection; care management optimization

  • Energy benefit: Services business with minimal energy intensity

  • Healthcare catalyst: Aging population drives membership growth; Optum platform scales

5. Intuitive Surgical (ISRG)

  • AI advantage: Robotic surgery platforms integrate machine learning for outcome improvements

  • Energy benefit: Minimal energy footprint; knowledge-intensive business

  • Healthcare catalyst: Aging population requires more surgical interventions; global expansion

The Contrarian Plays: Underestimated Recovery Stories

Utilities (Selective)

  • The bet: Near-term capex surge ($250B+ annually) positions grid operators for long-term dominance

  • Winners: NextEra Energy NEE, Duke Energy DUK—execution on buildout

  • Losers: Utilities delaying investment face obsolescence

Traditional Semiconductors (Intel)

  • The thesis: Energy deflation makes U.S. fabs competitive again; CHIPS Act subsidies de-risk investment

  • Risk: Execution turnaround required; competitive position deteriorated significantly

Banks (Regional)

  • The setup: AI operational efficiency + energy-light business model + wealth management for longer-living clients

  • Picks: M&T Bank MTB, Fifth Third FITB—technology investment leaders

  • Avoid: Banks with heavy commercial real estate exposure to obsolete office/retail

The Death Watch: Terminal Decline Candidates

Fossil Fuel Exposure

  • Structural headwinds: Demand peak by 2030; stranded asset risks; ESG capital flight

  • At risk: Coal producers (BTU, ARCH), pure-play E&Ps, pipeline operators with 30-year contracted life

Brick-and-Mortar Retail

  • Triple threat: AI-powered e-commerce + high energy costs (physical locations) + aging consumer digital shift

  • Vulnerable: Department stores (Macy's M, Nordstrom JWN), mall-based specialty retail

Legacy Manufacturing

  • Structural disadvantages: Limited AI integration + energy-intensive + aging workforce retirement

  • At risk: Auto suppliers without software pivot, commodity chemical producers

Commercial Real Estate (Office/Retail)

  • Secular decline: Remote work permanence + retail e-commerce shift + demographic patterns

  • Avoid: Office REITs (BXP, VNO), mall REITs (SPG selective)

Implementation Framework: Building a Future-Proof Portfolio

Core Holdings (40-50%)

High-conviction multi-scenario winners:

  • Eli Lilly LLY: 8-10%

  • Microsoft MSFT: 8-10%

  • NVIDIA NVDA: 6-8%

  • UnitedHealth UNH: 6-8%

  • JPMorgan Chase JPM: 6-8%

  • NextEra Energy NEE: 4-6%

Thematic Exposure (30-40%)

AI Infrastructure (15-20%):

  • Semiconductors: ASML, Broadcom, AMD

  • Cloud: Alphabet, Amazon

  • Software: Palantir, ServiceNow

Healthcare Innovation (10-15%):

  • Novo Nordisk, Intuitive Surgical, Dexcom

  • CRISPR/gene therapy: 2-3% allocation to high-risk/reward names

Energy Transition (5-10%):

  • Utilities: Duke, Constellation

  • Grid infrastructure: Quanta Services

  • Nuclear: Cameco CCJ

Contrarian/Value (10-20%)

Turnaround candidates with scenario optionality:

  • Select regional banks (5-7%)

  • Utility laggards with new management (3-5%)

  • Distressed healthcare services (2-3%)

Hedges (5-10%)

Portfolio insurance against scenario failures:

  • Energy MLPs for near-term spike protection

  • Treasury bonds for recession/deflation

  • Gold for geopolitical/inflation tail risks

Critical Reality Checks: What Could Go Wrong

AI Scenario Risks

  • Regulatory intervention (EU AI Act serves as template for U.S. restrictions)

  • Compute bottlenecks persist longer than expected (chip shortage 2.0)

  • Cybersecurity breaches undermine trust; adoption stalls

  • AGI timeline slips 5-10 years; expectations reset violently

Energy Scenario Risks

  • Grid infrastructure buildout delayed by permitting/labor shortages

  • China weaponizes battery materials monopoly (95% of graphite supply)

  • Climate events disrupt generation faster than capacity additions

  • Fusion commercialization fails; nuclear renaissance stalls

Healthcare Scenario Risks

  • GLP-1 adherence crisis worsens (already 50% discontinuation within 12 months)

  • Drug pricing regulation caps profitability; R&D investment declines

  • Healthcare cost inflation exceeds longevity economic benefits

  • Medicare/Social Security become politically unsustainable; benefits cut

The 80-Year Lesson: Humility in Forecasting

JPMorgan opens the report with a 1946 Atlantic article that correctly predicted baby boom impacts on schools, housing, and retirement systems—but completely missed industrialization, globalization, and the technology revolution.

The takeaway: directional accuracy matters more than precision. We know AI, energy, and healthcare will transform the economy. Specific timelines and magnitudes remain unknowable.

The companies that thrive won't be those with perfect predictions. They'll be those with adaptive capacity—balance sheets that weather near-term volatility, management teams that pivot as scenarios unfold, and business models with optionality across multiple futures.

Bottom Line: The Great Divergence

The performance gap between winners and losers will exceed any prior technological transition. Knowledge-intensive businesses with AI leverage, energy efficiency, and demographic tailwinds compound advantages. Capital-intensive businesses with physical constraints, energy intensity, and pension liabilities face terminal decline.

The S&P 500's equal-weighted return will dramatically underperform its cap-weighted return. Passive indexing faces a decade of reckoning. Active management resurges for those who correctly position for these three transformative scenarios.

The future belongs to companies that treat 2025 as the beginning of a new economic era—not the continuation of the last one.

Disclosure: This analysis is for informational purposes only and does not constitute investment advice. All investments carry risk, including loss of principal. Conduct your own due diligence and consult with financial advisors before making investment decisions. Stock mentions do not constitute recommendations to buy or sell securities.

This content is based on JPMorgan's "Navigating the Future" report (September 2025) and publicly available market data. Past performance does not guarantee future results. Market conditions, regulations, and company circumstances can change rapidly.

Table of Content

Share

Book your demo now!

a man wearing glasses and a black shirt

Parth Patel

Co-Founder